Presenting Exogenous Antigen to T Cells

Clifford V. Harding1, Lakshmi Ramachandra1

1 Case Western Reserve University, Cleveland, Ohio
Publication Name:  Current Protocols in Immunology
Unit Number:  Unit 16.2
DOI:  10.1002/0471142735.im1602s88
Online Posting Date:  February, 2010
GO TO THE FULL TEXT: PDF or HTML at Wiley Online Library

Abstract

Antigen processing and presentation experiments can be done with a wide variety of antigen‐presenting cells (APCs). Most experiments will use one of the “professional” APC types: dendritic cells (DCs), macrophages, and B lymphocytes. Other types of cells may be used for antigen presentation in some circumstances. Each type of professional APC has an important antigen‐presentation function, but the different APC types contribute to different aspects of the immune response. Therefore, selection of an APC type for study must include consideration of the stage or aspect of immune response that is to be modeled in the experiment. An important technical distinction for some types of experiments is whether the APCs are adherent or nonadherent, since this dictates the procedures that must be used to wash the cells as the medium is changed. Curr. Protoc. Immunol. 88:16.2.1‐16.2.18. © 2010 by John Wiley & Sons, Inc.

Keywords: antigen presenting cells; antigen processing; antigen presentation; T lymphocyte; T hybridoma cells

     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Table of Contents

  • Introduction
  • Basic Protocol 1: Antigen Processing and Presentation: A Simple Add‐Together System for Continuous Processing
  • Support Protocol 1: Detection of IL‐2 Using CTLL‐2 Cells and Alamar Blue
  • Alternate Protocol 1: Antigen Presentation by Fixed Adherent APCs to Detect Preprocessed Peptide
  • Alternate Protocol 2: Antigen Presentation by Fixed Nonadherent APCs to Detect Preprocessed Peptide
  • Alternate Protocol 3: Antigen Processing with Fixation After Incubation with Protein Antigen
  • Reagents and Solutions
  • Commentary
  • Literature Cited
  • Tables
     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Materials

Basic Protocol 1: Antigen Processing and Presentation: A Simple Add‐Together System for Continuous Processing

  Materials
  • Antigen‐presenting cells (APCs; unit 16.1), proliferating or nonproliferating, MHC‐compatible with T hybridoma cells; use macrophages or dendritic cells for particulate antigens.
  • Near‐confluent culture of T hybridoma cells
  • Complete DMEM‐10 medium ( appendix 2A)
  • Antigen stock solution (see recipe)
  • 96‐well flat‐bottom microtiter plates (round‐bottom for DCs)
  • Sorvall RT‐6000 centrifuge and HB‐1000 rotor (or equivalent) with tube and plate carriers
  • 8‐ or 12‐channel multichannel pipettor and sterile tips
  • Pipets, sterile
  • Additional reagents and equipment for counting viable cells ( appendix 3A& appendix 3B) and performing IL‐2 bioassay ( protocol 2 or unit 6.3)

Support Protocol 1: Detection of IL‐2 Using CTLL‐2 Cells and Alamar Blue

  Materials
  • Supernatants to be assayed for IL‐2, in 96‐well plate
  • CTLL‐2 cells in active log‐phase growth (see unit 6.3)
  • DMEM medium, serum free (Hyclone)
  • Complete DMEM‐10 medium ( appendix 2A)
  • Murine IL‐2 (BD Biosciences or any other company) diluted to 2000 U/ml in complete DMEM‐10 medium (rat or human IL‐2 can also be used)
  • Alamar Blue (Invitrogen); keep at 4°C for short‐term use and at −80°C for long‐term storage
  • 15‐ml conical tubes (Falcon)
  • Sorvall RT6000 refrigerated tabletop centrifuge and HB‐1000 rotor (or equivalent)
  • Spectrophotometer (with filters at 600 and 570 nm or 595 and 550 nm)
  • Additional reagents and equipment for counting viable cells ( appendix 3A& appendix 3B)

Alternate Protocol 1: Antigen Presentation by Fixed Adherent APCs to Detect Preprocessed Peptide

  • 2% (w/v) paraformaldehyde in PBS (see recipe)
  • Lysine wash solution (see recipe)

Alternate Protocol 2: Antigen Presentation by Fixed Nonadherent APCs to Detect Preprocessed Peptide

  • Confluent cultures of nonadherent antigen‐presenting transformed B cells (e.g., CH‐27)
  • 2% (w/v) paraformaldehyde in PBS (see recipe)
  • Lysine wash solution (see recipe)
  • 15‐ and 50‐ml centrifuge tubes, sterile

Alternate Protocol 3: Antigen Processing with Fixation After Incubation with Protein Antigen

  • Complete DMEM‐10 medium lacking antibiotics (prepare as in appendix 2A, but omit antibiotics, for experiments using live bacteria)
  • Antigen: bacteria or bacteria expressing non‐endogenous protein
  • 2% (w/v) paraformaldehyde in PBS (see recipe)
  • Lysine wash solution (see recipe)
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Figures

Videos

Literature Cited

Literature Cited
   Ackerman, A.L., Kyritsis, C., Tampé, R., and Cresswell, P. 2005. Access of soluble antigens to the endoplasmic reticulum can explain cross‐presentation by dendritic cells. Nat. Immunol. 6:107‐113.
   Ackerman, A.L., Giodini, A., and Cresswell, P. 2006. A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells. Immunity 25:607‐617.
   Adorini, L., Ullrich, S.J., Appella, E., and Fuchs, S. 1990. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II‐restricted T cells. Nature 346:63‐66.
   Ahmed, S.A., Gogal, R.M. Jr., and Walsh, J.E. 1994. A new rapid, and simple non‐radioactive assay to monitor and determine the proliferation of lymphocytes: An alternative to 3H‐thymidine incorporation assay. J. Immunol. Methods 170:211‐224.
   Arnold, D., Driscoll, J., Androlewicz, M., Hughes, E., Cresswell, P., and Spies, T. 1992. Proteasome subunits encoded in the MHC are not generally required for the processing of peptides. Nature 360:171‐174.
   Attaya, M., Jameson, S., Martinex, C.K., Hermel, E., Aldrich, C., Forman, J., Lindahl, K.F., Bevan, M.J., and Monaco, J.J. 1992. Ham‐2 corrects the class I antigen‐processing defect in RMA‐S cells. Nature 355:647‐649.
   Bakke, O. and Dobberstein, B. 1990. MHC class II‐associated invariant chain contains a sorting signal for endosomal compartments. Cell 63:707‐716.
   Bikoff, E.K., Huang, L.‐Y., Episkopou, V., van Meerwijk, J., Germain, R.N., and Robertson, E.J. 1993. Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression. J. Exp. Med. 177:1699‐1712.
   Brooks, A.G., Campbell, P.L., Reynolds, P., Gautam, A.M., and McCluskey, J. 1994. Antigen presentation and assembly by mouse I‐Ak class II molecules in human APC containing deleted or mutated HLA‐DM genes. J. Immunol. 153:5382‐5392.
   Brunt, L.M., Portnoy, D.A., and Unanue, E.R. 1990. Presentation of Listeria monocytogenes to CD8+ T cells requires secretion of hemolysin and intracellular bacterial growth. J. Immunol. 145:3540‐3546.
   Burgert, H.‐G., White, J., Weltzien, H.‐U., Marrack, P., and Kappler, J.W. 1989. Reactivity of V beta 17a+ CD8+ T cell hybrids: Analysis using a new CD8+ T cell fusion partner. J. Exp. Med. 170:1887‐1904.
   Canaday, D.H., Gehring, A., Leonard, E.G., Eilertson, B., Schreiber, J.R., Harding, C.V., and Boom, W.H. 2003. T cell hybridomas from HLA‐transgenic mice as tools for analysis of human antigen processing. J. Immunol. Methods 281:129‐142.
   De Bruijn, M.L.H., Nieland, J.D., Harding, C.V., and Melief, C.J.M. 1992. Processing and presentation of intact hen egg white lysozyme by dendritic cells. Eur. J. Immunol. 22:2347‐2352.
   Denzin, L.K., Robbins, N.F., Carboy‐Newcomb, C., and Cresswell, P. 1994. Assembly and intracellular transport of HLA‐DM and correction of the class II antigen‐processing defect in T2 cells. Immunity 1:595‐606.
   Diment, S. and Shinde, S. 1995. Selective processing of exogenous antigens by antigen‐presenting cells with deleted MHC genes. J. Immunol. 154:530‐535.
   Fehling, H.J., Swat, W., Laplace, C., Kühn, R., Rajewsky, K., Müller, U., and von Boehmer, H. 1994. MHC class I expression in mice lacking the proteasome subunit LMP‐7. Science 265:1234‐1237.
   Fling, S.P., Arp, B., and Pious, D. 1994. HLA‐DMA and ‐DMB genes are both required for MHC class II/peptide complex formation in antigen‐presenting cells. Nature 368:554‐558.
   Fung‐Leung, W.‐P., Surh, C.D., Liljedahl, M., Pang, J., Leturcq, D., Peterson, P.A., Webb, S.R., and Karlsson, L. 1996. Antigen presentation and T cell development in H2‐M‐deficient mice. Science 271:1278‐1281.
   Gillis, S., Ferm, M.M., Ou, W., and Smith, K.A. 1978. T cell growth factor: Parameters of production and a quantitative microassay for activity. J. Immunol. 120:2027‐2032.
   Glimcher, L.H., Hamano, T., Asofsky, R., Sachs, D.H., Pierres, M., Samelson, L.E., Sharrow, S.O., and Paul, W.E. 1983. IA mutant functional antigen‐presenting cell lines. J. Immunol. 130:2287‐2294.
   Griffin, J.P., Chu, R., and Harding, C.V. 1997. Early endosomes and a late endocytic compartment generate different peptide‐class II MHC complexes via distinct processing mechanisms. J. Immunol. 158:1523‐1532.
   Guermonprez, P., Valladeau, J., Zitvogel, L., Thery, C., and Amigorena, S. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20:621‐667.
   Guermonprez, P., Saveanu, L., Kleijmeer, M., Davoust, J., Van Endert, P., and Amigorena, S. 2003. ER‐phagosome fusion defines an MHC class I cross‐presentation compartment in dendritic cells. Nature 425:397‐402.
   Harding, C.V. 1992. Electroporation of exogenous antigen into the cytosol for antigen processing and class I major histocompatibility complex (MHC) presentation: weak base amines and hypothermia (18°C) inhibit the class I MHC processing pathway. Eur. J. Immunol. 22:1865‐1869.
   Harding, C.V. 1994. Techniques for studying phagocytic processing of bacteria for class I or II MHC‐restricted antigen recognition by T lymphocytes. Methods Cell Biol. 45:307‐320.
   Harding, C.V. 1995. Phagocytic processing of antigens for presentation by MHC molecules. Trends Cell Biol. 5:105‐109.
   Harding, C.V. 1996. Class II antigen processing: Analysis of compartments and functions. Crit. Rev. Immunol. 16:13‐29.
   Harding, C.V. and Unanue, E.R. 1989. Antigen processing and intracellular Ia. Possible roles of endocytosis and protein synthesis in Ia function. J. Immunol. 142:12‐19.
   Harding, C.V. and Geuze, H.J. 1992. Class II MHC molecules are present in macrophage lysosomes and phagolysosomes that function in the phagocytic processing of Listeria monocytogenes for presentation to T cells. J. Cell Biol. 119:531‐542.
   Harding, C.V., Collins, D.S., Kanagawa, O., and Unanue, E.R. 1991. Liposome‐encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation. J. Immunol. 147:2860‐2863.
   Harding, C.V., France, J., Song, R., Farah, J.M., Chatterjee, S., Iqbal, M., and Siman, R. 1995. Novel dipeptide aldehydes are proteasome inhibitors and block the MHC‐I antigen processing pathway. J. Immunol. 155:1767‐1755.
   Harding, C.V., Roof, R.W., and Unanue, E.R. 1989. Turnover of Ia‐peptide complexes is facilitated in viable antigen‐presenting cells: Biosynthetic turnover of Ia vs. peptide exchange. Proc. Natl. Acad. Sci. U.S.A. 86:4230‐4234.
   Haughton, G., Arnold, L.W., Bishop, G.A., and Mercolino, T.J. 1986. The CH series of murine B cell lymphomas: Neoplastic analogues of Ly‐1+ normal B cells. Immunol. Rev. 93:35‐51.
   Houde, M., Bertholet, S., Gagnon, E., Brunet, S., Goyette, G., Laplante, A., Princiotta, M.F., Thibault, P., Sacks, D., and Desjardins, M. 2003. Phagosomes are competent organelles for antigen cross‐presentation. Nature 425:402‐406.
   Kenty, G., Martin, W.D., Van Kaer, L., and Bikoff, E.K. 1998. MHC class II expression in double mutant mice lacking invariant chain and DM functions. J. Immunol. 160:606‐614.
   Lamb, C.A., Yewdell, J.W., Bennink, J.R., and Cresswell, P. 1991. Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus. Proc. Natl. Acad. Sci. U.S.A. 88:5998‐6002.
   Lotteau, V., Teyton, L., Peleraux, A., Nilsson, T., Karlsson, L., Schmid, S.L., Quaranta, V., and Peterson, P.A. 1990. Intracellular transport of class II MHC molecules directed by invariant chain. Nature 348:600‐605.
   Martin, W.D., Hicks, G.G., Mendiratta, S.K., Leva, H.I., Ruley, H.E., and Van Kaer, L. 1996. H2‐M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell 84:543‐550.
   Matousek, M.P., Nedrud, J.G., Cieplak, W. Jr., and Harding, C.V. 1998. Inhibition of class II major histocompatibility complex antigen processing by Escherichia coli heat‐labile enterotoxin requires an enzymatically active A subunit. Infect. Immun. 66:3480‐3484.
   Miller, J. and Germain, R.N. 1986. Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain. J. Exp. Med. 164:1478‐1489.
   Miyazaki, T., Wolf, P., Tourne, S., Waltzinger, C., Dierich, A., Barois, N., Ploegh, H., Benoist, C., and Mathis, D. 1996. Mice lacking H2‐M complexes, enigmatic elements of the MHC class II peptide‐loading pathway. Cell 84:531‐541.
   Momburg, F., Ortiz‐Navarrete, V., Neefjes, J.J., Goulmy, E., van de Wal, Y., Spits, H., Powis, S.J., Butcher, G.W., Howard, J.C., Walden, P., and Hammerling, G.J. 1992. Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation. Nature 360:174‐177.
   Momburg, F., Fuchs, S., Drexler, J., Busch, R., Post, M., Hammerling, G.J., and Adorini, L. 1993. Epitope‐specific enhancement of antigen presentation by invariant chain. J. Exp. Med. 178:1453‐1458.
   Moore, M.W., Carbone, F.R., and Bevan, M.J. 1988. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54:777‐785.
   Morris, P., Shaman, J., Attaya, M., Amaya, M., Goodman, S., Bergman, C., Monaco, J.J., and Mellins, E. 1994. An essential role for HLA‐DM in antigen presentation by class II major histocompatibility molecules. Nature 368:551‐554.
   Morrison, L.A., Lukacher, A.E., Braciale, V.L., Fan, D.P., and Braciale, T.J. 1986. Differences in antigen presentation to MHC class I‐ and class II‐restricted influenza virus‐specific cytolytic T lymphocyte clones. J. Exp. Med. 163:903‐921.
   Nadimi, F., Moreno, J., Momburg, F., Heuser, A., Fuchs, S., Adorini, L., and Hämmerling, G.J. 1991. Antigen presentation of egg‐white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II–associated invariant chain. Eur. J. Immunol. 21:1255‐1263.
   Neefjes, J.J. and Ploegh, H.L. 1992. Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistant ab heterodimers in endosomes. EMBO J. 11:411‐416.
   Nuchtern, J.G., Bonifacine, J.S., Biddison, W.E., and Klausner, R.D. 1989. Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation. Nature 339:223‐226.
   Oh, Y.K., Harding, C.V., and Swanson, J.A. 1997. The efficiency of antigen delivery from macrophage phagosomes into cytoplasm for MHC class I‐restricted antigen presentation. Vaccine 15:511‐518.
   Peterson, M. and Miller, J. 1992. Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41. Nature 357:596‐598.
   Pfeifer, J., Wick, M.J., Russell, D., Normark, S., and Harding, C.V. 1992. Recombinant Escherichia coli express a defined, cytoplasmic epitope that is efficiently processed in macrophage phagolysosomes for class II MHC presentation to T lymphocytes. J. Immunol. 149:2576‐2584.
   Pfeifer, J.D., Wick, M.J., Roberts, R.L., Findlay, K., Normark, S.J., and Harding, C.V. 1993. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361:359‐362.
   Pinet, V., Vergelli, M., Martin, R., Bakke, O., and Long, E.O. 1995. Antigen presentation mediated by recycling of surface HLA‐DR molecules. Nature 375:603‐606.
   Reddy, R., Zhou, F., Huang, L., Carbone, F., Bevan, M., and Rouse, B.T. 1991. pH sensitive liposomes provide an efficient means of sensitizing target cells to class I restricted CTL recognition of a soluble protein. J. Immunol. Methods 141:157‐163.
   Riberdy, J.M., Newcomb, J.R., Surman, M.J., Barbosa, J.A., and Cresswell, P. 1992. HLA‐DR molecules from an antigen‐processing mutant cell line are associated with invariant chain peptides. Nature 360:474‐477.
   Rock, K.L. 2003. The ins and outs of cross‐presentation. Nat. Immunol. 4:941‐943.
   Rock, K.L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., and Goldberg, A.L. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761‐771.
   Sekaly, R.P., Tonelle, C., Strubin, M., Mach, B., and Long, E.O. 1986. Cell surface expression of class II histocompatibility antigens occurs in the absence of the invariant chain. J. Exp. Med. 164:1490‐1504.
   Shen, L., Sigal, L.J., Boes, M., and Rock, K.L. 2004. Important role of cathepsin S in generating peptides for TAP‐independent MHC class I crosspresentation in vivo. Immunity 21:155‐165.
   Spies, T., Cerundolo, V., Colonna, M., Cresswell, P., Townsend, A., and DeMars, R. 1992. Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature 355:644‐646.
   St.‐Pierre, Y. and Watts, T.H. 1990. MHC class II‐restricted presentation of native protein antigen by B cells is inhibitable by cycloheximide and brefeldin A. J. Immunol. 145:812‐818.
   Stebbins, C.C., Loss, G.E. Jr., Elias, C.G., Chervonsky, A., and Sant, A.J. 1995. The requirement for DM in class II‐restricted antigen presentation and SDS‐stable dimer formation is allele and species dependent. J. Exp. Med. 181:223‐234.
   Stockinger, B., Pessara, U., Lin, R.H., Habicht, J., Grez, M., and Koch, N. 1989. A role of Ia‐associated invariant chains in antigen processing and presentation. Cell 56:683‐689.
   Sweetser, M.T., Morrison, L.A., Braciale, V.L., and Braciale, T.J. 1989. Recognition of pre‐processed endogenous antigen by class I but not class II MHC‐restricted T cells. Nature 342:180‐182.
   Tourne, S., Miyazaki, T., Oxenius, A., Klein, L., Fehr, T., Kyewski, B., Benoist, C., and Mathis, D. 1997. Selection of a broad repertoire of CD4+ T cells in H‐2Ma0/0 mice. Immunity 7:187‐195.
   Unanue, E.R., Harding, C.V., Luescher, I.F., and Roof, R.W. 1989. Antigen‐binding function of class II MHC molecules. Cold Spring Harb. Symp. Quant. Biol. 54:383‐392.
   Van Kaer, L., Aston‐Rickardt, P.G., Ploegh, H.L., and Tonegawa, S. 1992. TAP1 mutant mice are deficient in antigen presentation, surface class I molecules and CD4‐8+ T cells. Cell 71:1205‐1214.
   Van Kaer, L., Ashton‐Rickardt, P.G., Eichelberger, M., Gaczynska, M., Nagashima, K., Rock, K.L., Goldberg, A.L., Doherty, P.C., and Tonegawa, S. 1994. Altered peptidase and viral‐specific T cell response in LMP2 mutant mice. Immunity 1:533‐541.
   Viville, S., Neefjes, J., Lotteau, V., Dierich, A., Lemeur, M., Ploegh, H., Benoist, C., and Mathis, D. 1993. Mice lacking the MHC class II‐associated invariant chain. Cell 72:635‐648.
   Yewdell, J.W. and Bennink, J.R. 1989. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes. Science 239:637‐640.
   Yewdell, J., Lapham, C., Bacik, I., Spies, T., and Bennink, J. 1994. MHC‐encoded proteasome subunits LMP2 and LMP7 are not required for efficient antigen presentation. J. Immunol. 152:1163‐1170.
   Zhou, X., Momburg, F., Liu, T., Abdel Motal, U.M., Jondal, M., Hammerling, G.J., and Ljunggren, H.G. 1994. Presentation of viral antigens restricted by H‐2Kb, Db or Kd in proteasome subunit LMP2‐ and LMP7‐deficient cells. Eur. J. Immunol. 24:1863‐1868.
   Ziegler, H.K. and Unanue, E.R. 1982. Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc. Natl. Acad. Sci. U.S.A. 79:175‐178.
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library